Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization.

J Clin Med · 2019 · PMC7020033 · PMID 31881761

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

However, there is a clear trend that previous systemic therapy is associated with decreased survival (7.3 vs. 13.1 months in our study), which has been confirmed by other studies [ 22 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.